Muhi S, Schmidt S, Marshall J, OBrien D, Johnson P, McCarthy J
PLoS Negl Trop Dis. 2025; 19(2):e0012593.
PMID: 39908304
PMC: 11819514.
DOI: 10.1371/journal.pntd.0012593.
Naemiratch B, Kulpijit N, Ruangkajorn S, Day N, Prachumsri J, Cheah P
BMC Med Ethics. 2025; 26(1):14.
PMID: 39875955
PMC: 11773921.
DOI: 10.1186/s12910-024-01160-7.
Eberts J, Eyal N, Banerjee S
Indian J Med Res. 2024; 160(3&4):262-266.
PMID: 39632640
PMC: 11619065.
DOI: 10.25259/IJMR_985_2024.
Pinheiro A, Kazura J, Pinheiro A, Schmaier A
Front Cell Infect Microbiol. 2023; 13:1184896.
PMID: 37637466
PMC: 10448822.
DOI: 10.3389/fcimb.2023.1184896.
Eberts J, Zimmer-Harwood P, Elsey J, Fraser-Urquhart A, Smiley T
Clin Infect Dis. 2023; 77(Suppl 3):S224-S230.
PMID: 37579204
PMC: 10425139.
DOI: 10.1093/cid/ciad350.
Perceptions and acceptability of the controlled human malaria infection (CHMI) model in The Gambia: a qualitative study.
Dabira E, Fehr A, Beloum N, Van Geertruyden J, Achan J, Erhart A
Sci Rep. 2023; 13(1):8708.
PMID: 37248260
PMC: 10226436.
DOI: 10.1038/s41598-023-35752-x.
Better recognition for research participants: what society should learn from covid-19.
Kraft S, Rohrig A, Williams A, Shah S
BMJ. 2023; 380:e071178.
PMID: 36649969
PMC: 11200266.
DOI: 10.1136/bmj-2022-071178.
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials.
Marsh A, Magalhaes M, Peeler M, Rose S, Darton T, Eyal N
PLoS One. 2022; 17(11):e0275823.
PMID: 36322529
PMC: 9629635.
DOI: 10.1371/journal.pone.0275823.
Patients' knowledge about their involvement in clinical trials. A non-randomized controlled trial.
Juan-Salvadores P, Michel Gomez M, Jimenez Diaz V, Martinez Reglero C, Iniguez Romo A
Front Med (Lausanne). 2022; 9:993086.
PMID: 36203759
PMC: 9531127.
DOI: 10.3389/fmed.2022.993086.
Controlled Human Infection Models To Accelerate Vaccine Development.
Choy R, Louis Bourgeois A, Ockenhouse C, Walker R, Sheets R, Flores J
Clin Microbiol Rev. 2022; 35(3):e0000821.
PMID: 35862754
PMC: 9491212.
DOI: 10.1128/cmr.00008-21.
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using in Uganda.
Egesa M, Ssali A, Tumwesige E, Kizza M, Driciru E, Luboga F
Glob Bioeth. 2022; 33(1):78-102.
PMID: 35814190
PMC: 9258062.
DOI: 10.1080/11287462.2022.2091503.
Systems biology of malaria explored with nonhuman primates.
Galinski M
Malar J. 2022; 21(1):177.
PMID: 35672852
PMC: 9172618.
DOI: 10.1186/s12936-022-04199-2.
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.
Chi P, Owino E, Jao I, Bejon P, Kapulu M, Marsh V
BMC Med Ethics. 2022; 23(1):46.
PMID: 35443642
PMC: 9019790.
DOI: 10.1186/s12910-022-00783-y.
"At first, I was very afraid"-a qualitative description of participants' views and experiences in the first Human Infection Study in Malawi.
Toto N, Gooding K, Kapumba B, Jambo K, Rylance J, Burr S
Wellcome Open Res. 2022; 6:89.
PMID: 35187267
PMC: 8825950.
DOI: 10.12688/wellcomeopenres.16587.2.
Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.
Chi P, Owino E, Jao I, Olewe F, Ogutu B, Bejon P
Trials. 2021; 22(1):494.
PMID: 34311781
PMC: 8313115.
DOI: 10.1186/s13063-021-05455-7.
Exploring willingness to participate in future Human Infection Studies in Lusaka, Zambia: A nested qualitative exploratory study.
Kunda-Ngandu E, Chirwa-Chobe M, Mwamba C, Chipungu J, Ngandu E, Mwanyungwi Chinganya H
PLoS One. 2021; 16(7):e0254278.
PMID: 34242320
PMC: 8270142.
DOI: 10.1371/journal.pone.0254278.
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Jamrozik E, Littler K, Bull S, Emerson C, Kang G, Kapulu M
Vaccine. 2020; 39(4):633-640.
PMID: 33341309
PMC: 7598752.
DOI: 10.1016/j.vaccine.2020.10.075.
Towards a fair and transparent research participant compensation and reimbursement framework in Vietnam.
Sansom L, Minh T, Hill I, Nguyen Than Ha Q, Trong T, Vidaillac C
Int Health. 2020; 12(6):533-540.
PMID: 33165550
PMC: 7651161.
DOI: 10.1093/inthealth/ihaa066.
Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?.
Jamrozik E, Selgelid M
J Med Ethics. 2020; 46(12):835-836.
PMID: 33154089
PMC: 7719901.
DOI: 10.1136/medethics-2020-106900.
Payment in challenge studies: ethics, attitudes and a new payment for risk model.
Grimwade O, Savulescu J, Giubilini A, Oakley J, Osowicki J, Pollard A
J Med Ethics. 2020; 46(12):815-826.
PMID: 32978306
PMC: 7719900.
DOI: 10.1136/medethics-2020-106438.